Cost-benefit Analysis of Sodium Intake Reduction Policy in Korea
Article information
Korean J Community Nutr. 2012;17(3):341-352
Publication date (electronic) : 2012 June 30
doi :
https://doi.org/10.5720/kjcn.2012.17.3.341
Received 2012 February 29; Revised 2012 April 06; Accepted 2012 May 15.
Abstract
It is well established that excessive sodium intake is related to a higher incidence of chronic diseases such as hypertension, stroke, coronary heart disease, cardiovascular disease and gastric cancer. Although the upper limit of the current sodium intake guideline by WHO is set at 2,000 mg/day for adults, sodium intake of Koreans is well over 4,700 mg/capita/day implying an urgent need to develop and implement sodium intake reduction policy at the national level. This study investigated the cost-effectiveness of the sodium intake reduction policy, for the first time, in Korea. Analyses were performed using most recent and representative data on national health insurance statistics, healthcare utilization, employment information, disease morbidity/mortality, etc. The socioeconomic benefits of the policy, resulting from reduced morbidity of those relevant diseases, included lower medical expenditures, transportation costs, caregiver cost for inpatients and income losses. The socioeconomic benefits from diminished mortality included reductions in earning losses and welfare losses caused by early deaths. It is estimated that the amount of total benefits of reducing sodium intake from 4.7 g to 3.0 g is 12.6 trillion Korean Won; and the size of its cost is 149 billion Won. Assuming that the effect of sodium intake reduction would become gradually evident over a 5-year period, the implied rate of average return to the sodium reduction policy is 7,790% for the following 25 years, suggesting a very high cost-effectiveness. Accordingly, development and implementation of a mid-to-long term plan for a consistent sodium intake reduction policy is extremely beneficial and well warranted.
Keywords: sodium intake reduction; health; cost-benefit analysis
Notes
This research was supported by a grant (11162KFDA163) from Korea Food & Drug Administration in 2011.
References
1. Ahn BC, Joung H. Socioeconomic cost of obesity in Korea. Korean J Nutr 2005. 38(9)786–792.
2. Blaustein MP, Hamlyn JM. Pathogenesis of essential hypertension : a link between dietary salt and high blood pressure. Hypertension 1991. 18(5 Suppl)III184–III195.
3. Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB. Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 2000. 13(3)169–177.
4. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M. Intersalt Cooperative Research Group. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ 1996. 312(7041)1249–1253.
5. Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Cost-effectiveness analysis of hypertension guidelines in South Africa. Circulation 2005. 1123569–3576.
6. Gibson J, Stillman S, Mckenzie D, Rohorua H. Natural experiment evidence on the effect of migration on blood pressure and hypertension. IZA Discussion Paper No. 5232 2010.
7. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004. (3)CD004937.
8. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2008. 23(6)363–384.
9. He J, Oqden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999. 282(21)2027–2034.
10. INTERSALT Cooperative Research Group. INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988. 297(6644)319–328.
11. Joffres MR, Campbell NR, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol 2007. 23(6)437–443.
12. Jung YH, Ko SJ. Estimating socioeconomic cost of five major diseases. Korean J Public Finance 2004. 18(2)77–104.
13. Jung YH, Ko SJ. The socioeconomic cost of diseases in Korea. J Prev Med Public Health 2006. 39(6)499–504.
14. Korea Employment Information Service. 2009 Occupational employment statistics 2010. cited 2011 May 20. Available from http://survey.keis.or.kr.
15. Korea Food & Drug Administration. Sodium reduction initiative - promoters' meeting 2011. Press Release 26/12/2011;
16. Korea Food & Drug Administration. Korea Health Industry Development Institute. Cost-benefit analysis of sodium intake reduction policy and international collaboration with WHO for establishing sodium intake guidelines 2012.
17. Korean Nutrition Society. Dietary reference intakes for Koreans 2010. 1st revisionth ed. Seoul: Hanareum; 367–381.
18. Lee C. In-utero exposure to the Korean war and its long-term effects on health and economic outcomes 2011. In : 2012 ASSA Meetings.
19. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005. 85(2)679–715.
20. Ministry of Employment and Labor. Report on 2009 Wage Structure Survey 2010. cited 2011 May 20. Available from http://www.moel.go.kr.
21. Ministry of Health and Welfare. Korea Centers for Disease Control & Prevention. Korea Health Statistics 2007: Korea National Health and Nutrition Examination Survey (KNHANES IV-1) 2007 2008.
22. Ministry of Health and Welfare. Korea Centers for Disease Control & Prevention. Korea Health Statistics 2008: Korea National Health and Nutrition Examination Survey (KNHANES IV-2) 2008 2009.
23. Ministry of Health and Welfare. Korea Centers for Disease Control & Prevention. Korea Health Statistics 2009: Korea National Health and Nutrition Examination Survey (KNHANES IV-3) 2009 2010.
24. Ministry of Health and Welfare. Korea Centers for Disease Control & Prevention. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1) 2010 2011.
25. Ministry of Health and Welfare. Korea Institute of Health and Social Affairs. The third Korea National Health & Nutrition Examination Survey (KNHANES III), 2005 - Health Interview Survey 2006.
26. Murray CJL, Lauer JA, Hutubessy RCW, Niessen L, Tomijima N, Rodgers A, Lawes CMM, Evans DB. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003. 361(9359)717–725.
27. National Health Insurance Corporation. Health Insurance Review & Assessment Service. 2008 National Health Insurance Statistical Yearbook 2009. cited 2011 March 10. Available from http://www.nhic.or.kr.
28. National Health Insurance Corporation. Health Insurance Review & Assessment Service. 2009 National Health Insurance Statistical Yearbook 2010. cited 2011 February 10. Available from http://www.nhic.or.kr.
29. National Health Insurance Corporation. Health Insurance Policy Research Institute. 2009 Survey on medical expenditure of patients insured by National Health Insurance 2010. cited 2011 March 10. Available from http://www.nhic.or.kr.
30. Rhee M-Y, Yang SJ, Oh SW, Park Y, Kim C-i, Park H-K, Park SW, Park C-Y. Novel genetic variations associated with salt sensitivity in the Korean population. Hypertens Res 2011. 34(5)606–611.
31. Rosen S. In : Ashenfelter O, Layard R, eds. The theory of equalizing differences. Handbook of Labor Economics 1986. Volume 1New York NY: North-Holland; 641–692s.
32. Selmer RM, Kristiansen IS, Haglerod A, Graff-Iversen S, Larsen HK, Meyer HE, Bønaa KH, Thelle DS. Cost and health consequences of reducing population intake of salt. J Epidemiol Community Health 2000. 54(9)697–702.
33. Stamler J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 1997. 65(2 Suppl)626S–642S.
34. Stamler R. Implications of the INTERSALT study. Hypertension 1991. 17(1 Suppl)I16–I20.
35. Statistics Korea. 2009 Economically Active Population Survey 2010. cited 2011 May 15. Available from http://kosis.go.kr.
36. Statistics Korea. Annual Report on the Cause of Death Statistics (2010) 2011. cited 2011 February 16. Available from http://kostat.go.kr.
37. Strazzullo P, D'Elia L, Kandala N-B, Cappuccio F. Salt intake, stroke, and cardiovascular disease: meta-anlaysis of prospective studies. BMJ 2009. 339b4567.
38. Tsugane S, Sasazuki S, Kobayashi M, Sasaki S. Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer 2004. 90(1)128–134.
39. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001. 357(9259)848–851.
40. World Health Organization. Diet, nutrition and the prevention of chronic diseases. ort of a joint WHO/FAO Expert Consultation 2003. Geneva: World Health Organization; (WHO Technical report series, No. 916).
41. World Health Organization. Creating an enabling environment for population-based salt reduction strategies. Report of a joint technical meeting held by WHO and the Food Standards Agency 2010a. July 2010; United Kingdom.
42. World Health Organization. International statistical classification of diseases and related health problems, 10th Revision. ICD-10 Version:2010 2010b. cited 2011 March 10. Available from http://apps.who.int/classifications/icd10/browse/2010/en.
43. World Health Organization. Call for public comments on the scoping of sodium and potassium recommendations 2011. cited 2011 February 10. Available from http://www.who.int/nutrition/events/NUGAG_dietandhealth_subgroup_call_public_comment_scope_of_Na_K.pdf.
44. World Health Organization. Call for public comments - Draft WHO Guidelines sodium and potassium 2012. cited 2012 February 3. Available from http://www.who.int/nutrition.
Article information Continued
Copyright © 2012 The Korean Society of Community Nutrition
